SCHEMBL6340253

SCHEMBL6340253

CCN(C(=O)N1C(=O)NC(C)=C(C(=O)OCc2ccccc2)C1c1cccc(Cl)c1)c1cccnc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
NPSR1 Q6W5P4 2/20 0.49
HSD17B10 Q99714 1/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
PDE1C Q14123 1/20 0.48
CACNA1F O60840 2/20 0.47
CACNA1D Q01668 2/20 0.47
CACNA1S Q13698 2/20 0.47
CACNA1C Q13936 2/20 0.47
CYP3A4 P08684 2/20 0.45
GAA P10253 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
KDM4E B2RXH2 1/20 0.45
GPBAR1 Q8TDU6 3/20 0.44
CACNA1B Q00975 1/20 0.43
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6338024 0.92 PDE1C (0.50) ALDH1A1NPSR1HSD17B10LMNAPOLB
SCHEMBL6340731 0.88 CACNA1F (0.43) NPSR1CACNA1FCACNA1DCACNA1SCACNA1C
SCHEMBL6338173 0.86 PDE1C (0.53) NPSR1PDE1CCACNA1FCACNA1DCACNA1S
SCHEMBL6336408 0.83 PDE1C (0.57) NPSR1HSD17B10PDE1CCACNA1FCACNA1D
SCHEMBL6339672 0.81 PDE1C (0.52) NPSR1PDE1CCACNA1FCACNA1DCACNA1S
SCHEMBL6347405 0.81 CACNA1F (0.67) ALDH1A1NPSR1PDE1CCACNA1FCACNA1D
SCHEMBL6340251 0.81 ADRA1D (0.54) ALDH1A1NPSR1HSD17B10LMNAPOLB
SCHEMBL6346164 0.79 PDE1C (0.62) NPSR1PDE1CCACNA1FCACNA1DCACNA1S
SCHEMBL6340739 0.79 CACNA1F (0.45) NPSR1CACNA1FCACNA1DCACNA1SCACNA1C
SCHEMBL6338019 0.76 ADRA1D (0.55) ALDH1A1NPSR1HSD17B10PDE1CCACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6855716-B2 Dihydropyrimidine compounds and compositions containing the same AJINOMOTO CO., INC. (JP) 2005-02-15 US disclosed
US-20020143023-A1 Dihydropyrimidine compounds and compositions containing the same AJINOMOTO CO. INC (JP) 2002-10-03 US disclosed
EP-1193259-A1 DIHYDROPYRIMIDINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2002-04-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020143023-A1 Dihydropyrimidine compounds and compositions containing the same CACNA1B, CACNA1D, CACNA1G ALDH1A1 2543/4885NPSR1 1955/4885HSD17B10 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.